Microbiology Conferences | Call For Abstracts | Medical Microbiology Events | Applied Microbiology Meetings | USA | Europe | UK | Middle East | Asia Pacific

Call for Abstract

Scientific Program

7^th Euro Global Summit on Clinical Microbiology and Mycotoxins, will be organized around the theme “Microbiology Summit 2017: Amalgamating research, diagnosis and cure.”

Microbiology Summit 2017 is comprised of 17 tracks and 60 sessions designed to offer comprehensive sessions that address current issues in Microbiology Summit 2017.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Track 1:Disease Diagnosis and Prevention

Identification of a specific infectious agent for a precise infection or a disease is done in clinical presentation like for instance, in gastrointestinal disease and in bacterial skin infections. Diagnosis is done by consultation of patient’s medical history, physical examination and the diagnostic tests. Diagnostic microbiology laboratory plays a crucial role in diagnosis; however the conclusive analysis of the resulting causative agents is concluded only by experts. Isolating of microbiological culture is the primitive approach for isolation of the causative organism in the laboratory which is then closely followed by the biochemical tests and then advanced serological assays and the final step is the polymerase reactions. In drug resistance the microbial cell mechanically ceases the uptake of a drug, while some resist drugs eventually by formation of the Biofilm by annexing itself to the surfaces of medical device like catheters and prostheses. Regular intake of natural probiotics provide positive health benefits by improving gastrointestinal health by increasing the number of bacteria or by inhibiting pathogens.

Track 2:Entrepreneur Investments Meet

A key ingredient in successful entrepreneurship is self-knowledge. (Microbiology Summit-2017) aims to bring together all existing and budding bio entrepreneurs to share experiences and present innovations and challenges in microbiological and mycological community. Each year, over a million companies are started in the world with about 5–10 of them classified as high technology companies. Turning ideas into business ventures is tricky and the opportunity-recognition step is critical in new venture creation. This gestalt in the entrepreneur's perception of the relationship between the invention and final product is refined into a business model that describes how the venture will make money or provide an appropriate return to the potential investors. Biological science is complex and rapidly changing and requires a specialized knowledge to understand the value of the innovation and its competitive position in the industry. Although life scientists are typically the founders of biotech companies, studies have shown that the most successful high tech start-ups are founded by a team of two to three individuals with mixed backgrounds, substantial industry experience and a very clear market and product focus at founding. This three day community-wide conference will be a highly interactive forum that will bring experts in areas ranging from structural microbiology to signaling pathways to novel therapeutic approaches to the scientific hub. In addition to our outstanding speakers, we will also showcase short talks and poster presentations from submitted abstracts. The speakers will discuss how microbes can be engineered to report using computational inputs from their local environment. This session will include combined efforts of cutting edge synthetic biology research to highlight the current state, challenges and future of engineered microbial communities

Track 3:Bacterial diseases

Bacterial diseases constitutes infections whose essential causative organism is bacteria. In bacterial pathogens is the bacteria infects and causes a disease in the host whose cell it invaded in. However, not all bacteria are pathogenic and they have the ability to cause a disease. Bacteria also resides in host without harming it in a symbiotic relation and also helps in building a response against the invading foreign opportunistic bacteria from harming the host. Bacteria primarily produce two types of toxins called the Exotoxins and the Endotoxins. These toxins are soluble can be transported by both blood and lymph and causes cytotoxicity at remote tissue sites. Bacteria also infect skin, causing skin infections like Impetigo, Erysipelas and Cellulitis among numerous others. Urinary Tract Infection (UTIs) are mainly caused by Escherichia coli; Typhoid fever by Salmonella typhi. Bacterial infections are generally treated by antibiotics, which are further categorized as Bactericidal – Antibiotics that kill bacteria and Bacteriostatic – Antibiotics which prevent bacterial growth and hindering their metabolism. Profoundly extensive use of such antibiotics contributes to the swift advancement of the antibiotic resistance in the pathogenic bacterial populations.

World Congress on Mycotoxins February 27-28, 2017 Amsterdam, Netherlands, 9th International Virology Congress and Expo March 13-15, 2017 London, UK, 10th World Congress on Virology and Mycology May 11-12, 2017 Singapore, International Conference On Microbial Engineering May 29-31, 2017 Beijing, China, Global Pharmaceutical Microbiology Conference June 19-20, 2017 London, UK, International Conference on Fungal Diseases & Control September 25-26, 2017 Dubai, UAE, 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA, 2nd International Conference and Expo on Water Microbiology & Novel Technologies August 28-30, 2017 Philadelphia, USA,

Track 4:Viral Infections

Viral infections are quite prevalent, most typically seen are the common cold, hepatitis, influenza, measles, rabies, Dengue, diarrhea, AIDS , polio, smallpox, cold sores and genital herpes, Study of various ways through which viruses affect individuals are specified as viral pathogenesis. The purview of the disease/ infection caused by the virus is its virulence. When a virus invades into the host, the immune system starts producing specific/ impromptu antibodies that binds to the virus thereby neutralizing its virulence or kills them. Presence of such antibodies in blood serum detects if a host has ever been exposed to any given virus in the past. This is possible only with the help of specific tests such as ELISA. Vaccinations protect against diseases, by augmenting the production of antibodies. Monoclonal antibodies, are profoundly specific to a single virus, are typically used for detection in fluorescence microscopy. Additionally, viruses being used as gene vectors in the gene therapy of genetic diseases are also gaining momentum; similarly in phage therapy, use of the bacteriophages to encounter bacterial infections and diseases was effectual. The recent approach of genetically engineered viruses in nanobiotechnology is seen as the novel approach to combat various diseases at the genetic level.

Due to the rampant HCV infection and high insistence for such enhanced and effectual treatments, numerous estimates envisage the global industry for HCV treatment costs $20 billion annually, this decade.

Track 5:Medical Microbiology

The study of prevention, diagnosis and treatment of various infectious diseases is termed as Medical microbiology. Medical microbiology is the application of all non-pathogenic microbes for improving health and in prevention of epidemics, outbreak of various diseases. Microorganisms commonly causing infections are bacteria, fungi, parasites and viruses and also a viral infectious protein called as a prion. Detailed identification techniques used in laboratories are typically microbial culture followed by microscopy, Electron microscopy and biochemical tests and then genotyping. Medical microbiologists recommend treatment based on the report of a strain of microbe and the prevalent antibiotic resistances, precise site and source of infection, the probable toxicity of drugs and drug allergies. Drug resistance comprises chemically inactivating of a drug or a cell ceasing the uptake of a drug.

Track 5-1Microbial Diversity
Track 5-2Viruses and Infections
Track 5-3Mycology and its medical preventions
Track 5-4Diagnostic Microbiology
Track 5-5Latest trends in Medical Microbiology

Track 6: Host Pathogen Interactions

Host microorganism interaction takes place between a microorganism and a number. associate degree symptomless infection is that the one during which microorganism resides in host while not inflicting any harm; Microbes are often each hosts and pathogens and also the studies of microorganism pathologic process results in the identification of molecular variations between a morbific and a non-pathogenic bug. Microbial Virulence depends on host factors, like pathogenicity of associate degree avirulent bug in disorder host and conjointly the missing of the pathogenicity of virulent pathogens in immune hosts. The live of virulence is that the ability of a bug to cause illness in any animal, centralized to the Koch’s postulates.

Track 6-1Host-pathogen interface
Track 6-2Host-Pathogen Interaction and Human Disease
Track 6-3Host pathogen interaction in plants
Track 6-4The genetics of hostâ€“pathogen interaction

Track 7:Infectious diseases

Infectious diseases are caused by pathogenic microbes which spread either directly or indirectly from one person to another. These can be classified as either bacterial, viral, zoonotic, parasitic or fungal infection depending on causative agents. Most of infections are not lethal and organism is annihilated after the symptoms wane. The process requires immune mechanisms to kill the source of the pathogen. Specific acquired immunity antagonistic to the infectious diseases are mediated by either antibodies or by T lymphocytes. The immune response causes high fever, inflammation, and also has the probability to be devastating to a microbe. Phylodynamic models help in locating the epidemic and pandemic origins. The agile rate of evolution and growth in viruses allows molecular clocks to envisage the genetic sequences, thereby providing the precise rate of evolution of the virus.

Track 7-1Pandemic and epidemic diseases
Track 7-2Tropical diseases
Track 7-3Tuberculosis (TB)
Track 7-4HIV/AIDS
Track 7-5Hepatitis B
Track 7-6Antimicrobial Resistance
Track 7-7Emerging Respiratory Pathogens

Track 8: Microbial Biochemistry

Microbial biochemistry comprises of biochemical reactions in microbial growth, various modes and mechanisms/ processes of pathogenesis required in causing infection/ diseases in the host. It involves the study of microbial growth, microbial cell structure, microbial metabolism, primary and advanced functions and the interactions of biological macromolecules, like carbohydrates, proteins, Fatty Acids and Lipids and nucleic acids; which cater the skeletal aspect and basis of functions affiliated with life. Biochemical study of microbes is crucial in the processes of their action. Post genomic analyses, maintenance of mechanisms, & functional replication, integrating plasmid functions, conjugation systems and regulatory network are the key factors that play a vital role in metabolism of microbes. When monomers are co-linked to synthesize a polymer, dehydration occurs often resulting in assembly of different macromolecules in a much larger complexes.

Track 9:Dynamics and consequences of antimicrobial resistance

Antimicrobial resistance is an indispensable causatum which leads to millions of fatalities annaually. Infections now, are slowly getting untreatable, primarily because of the antimicrobial resistance. All microbes slowly are developing resistance against their microbial agents; like for instance fungi developed antifungal resistance, viruses started attenuating antiviral resistance and protozoa have developed antiprotozoal resistance. Bacterial antibiotic resistance confers a paramount threat of infection non-prevention in multitudes. Antibiotics should solitarily be used only/ if it is indispensable and precisely only when prescribed by a licensed health professional. To prevent or lower the factor of antimicrobial resistance, awareness for using Narrow-spectrum antibiotics should be taught. Antibiotic resistance is quite problematic and various policymakers and pharma industries help in tackllng resistance by supporting various innovative and novel approaches.

Track 9-1Clinical Impact of Antimicrobial Resistance
Track 9-2Human Microbiotica As A Reservoir For Antibiotic-Resistant Bacteria
Track 9-3Evolution And Transmission Of Antibiotic-Resistant Bacteria
Track 9-4Antibiotic Resistance
Track 9-5Antimicrobial Use and Antimicrobial Resistance

Track 10:Fungal Diseases

Applied Mycology is a Biological discipline comprising the study of fungi, their frame-work, their genetic and biochemical characteristics, taxonomy and their benefits especially as a primary source of wine, edible mushrooms, cheese, and their adverse effects with respect to their toxin or infection. Fungi and other organisms such as oomycetes and myxomycetes, often are economically crucial, as the pathogenic fungi affects animals by causing diseases like histoplasmosis. Recent studies asserts that mushrooms have hypoglycemic, immune system-enhancing, anti-pathogenic and anti-cancer drug development. Food spoilage induced by fungi and yeasts can be more compelling, notably in innumerable food groups particularly that are acidic and/or have low moisture content. Mycotoxicology is a sub-branch focusing on toxins produced by fungi, called mycotoxins. Fungi have an important role in the ecosystem as they break down and eventually decompose dead plants, animals and other organic matter; while some destructive fungi attack living organisms resulting in casualties to the forest industry. Fungi are also a discrete source of food, fuel, pharmaceuticals and pesticides. Being eukaryotes, fungi are an essential tool in various biotechnological applications and in bioremediation. The Global Healthcare industry was at its peak at USD 27,861.2 million in the year 2013 and is anticipated to grow at a CAGR of 7.1% to attain estimated USD 41,929.1 million by 2019.

Track 10-1 Fungal Diseases Types
Track 10-2Pathogenic fungi
Track 10-3Fungal Infections of the Skin
Track 10-4Opportunistic fungal infections
Track 10-5Fungal Disease of Cruciferous Crops
Track 10-6Illness & Prevention

Track 11: Parasitic Diseases

Study of the interaction of the parasite and their hosts is Parasitology. Medical parasitology has it’s congruence with the pathogenic parasites affecting humans, the diseases, clinical pathology and the response of the human’s immune system against these pathogenic Microorganism. It also deals with the different approaches of the infection and diagnosis, treatment, prevention & control. Additionally medical parasitology also comprises of structural based Drug Development, Epidemiological Studies and zoonosis. An interdisciplinary field, inveigled by Biochemistry, Immunology, Microbiology, and other applied life sciences. Parasites inhabit the host of a remarkably high immuno-potent immune system. Vector-borne infections are transferred via bite of an infected arthropod, for instance mosquitoes, ticks, bugs, sandflies and blackflies. Resistant parasitic worms developed resistance against other infectious agents although the mechanisms of resistance in protozoan parasites are not yet acknowledged. About 50% of known positive malarial cases are caused by P. vivax. Prevailing advancements in state-of-the-art diagnostic tools has ascertained new facets for colossal enhancements in parasitic detection. Control and dissolution of human parasitic diseases require innovative outlooks, notably in the fields of diagnostics, modeling, investigation, interpretation, scrutiny and public health response.The Global Animal Healthcare industry was venerated at US $27,861.2 million in 2013 and is envisaged to grow at a CAGR of about 7.1% to achieve an anticipated US $41,929.1 million by 2019.

Track 11-1Parasitic diseases symptoms
Track 11-2common parasitic diseases
Track 11-3Parasite in humans
Track 11-4 Parasite types
Track 11-5Diagnosis and Tests
Track 11-6Prevention and Risk Factors
Track 11-7parasitic infections

Track 12:Infection Control

Infection control is the forestalling/prevention of nosocomial infections. It is a part of the framework of the health care. Infection Control and Hospital Epidemiology are pertinent to the public health practice, interpolated in a particular health-care distribution system. Anti-infective agents, like for instance antibiotics - essentially antibacterial, antiviral, antifungal and antiprotozoal are readily accessible to annihilate infections. Infection control comprises elements relevant to the transmission of infections; either in the hospitals or other healthcare centers including prevention via hand hygiene, cleaning or disinfection or sanitization, vaccines or surveillance and probe of infections in a health-care domain and management. Sterilization kills all microorganisms- live or dominant. Sterilizers are categorized in heat, steam and liquid categories. Disinfection is wiping / killing of the live micro-organisms at room temperatures. Ultraviolet light (UV Light) is also used to sterilize the rooms of infected/ pre-disposed patients after discharge.The essential factor is that disinfection is less effective than sterilization because disinfection does not harm bacterial spores or dominant bacteria. Personal Protective Equipment (PPE) is few protective gears to be worn for protection against hazards of sterilizations or while using equipment. The primitive hazards in any given healthcare comprises of blood, saliva, other body fluids or aerosols that carry infectious agents like Hepatitis C, HIV, and other blood borne or fluid pathogen. PPE helps preventing contact with a potentially infectious agent by framing a physical barrier between the potential infectious agent and the healthcare professional.

The Global Infectious Disease industry is envisaged to reach $8.8 billion by 2017, growing at a compound annual growth rate (CAGR) of about 6% from 2010.

Track 12-1Infection control in healthcare facilities
Track 12-2Personal protective equipment
Track 12-3Vaccination of health care workers
Track 12-4Drugs and Vaccines
Track 12-5Antimicrobial surfaces and disinfection
Track 12-6Surveillance for infections

Track 13: Nosocomial Infections

Nosocomial Infection comprises infection which is struck from the hospital surroundings, staff, in-patients/out-patients, cleaners and other healthcare centers. These infections can be contracted in any of the health-care departments like- the Hospital environment or the Nursing Home, Rehabilitation Centers or other Clinical settings. Nosocomial Infections are relayed to the pre-disposed in such environments by an innumerable ways. Various Health care personnel can spread different infections via contaminated equipment, Soiled/unclean/non-disinfected bed linens and other clothes, blankets, pillows, or air droplets. These infections can spread either from outside of the hospital, from in-patient, staff that may be infected, or carriers, unknown sources. In most of the pathogenic microorganisms originate from the patient's own skin flora, also called as opportunistic microbes; after any surgical process or those procedures that compromises skin as the primary protective barrier. Albeit, the patient contracts the infection privy from their skin, the infection are considered to be nosocomial since it emanates in the hospital.

Track 13-1Nosocomial infection prevention
Track 13-2Hospital-acquired pneumonia
Track 13-3Nosocomial infection treatment
Track 13-4community acquired infection
Track 13-5Infection control and Prevention
Track 13-6Epidemiology

Track 14:Microbial Pathogenesis

Microbial pathogens embody microorganism, viruses, fungi, and parasites and along account for a major proportion of acute and chronic human diseases. Additionally to understanding the mechanisms by that varied pathogens cause human unwellness, analysis in microbic pathological process additionally addresses mechanisms of antimicrobial resistance and also the development of latest antimicrobial agents and vaccines. It covers biology, host-pathogen interaction and medicine associated with infectious agents, as well as microorganism, fungi, viruses and protozoa. microbic pathological process is committed to the study of the genomic, molecular and cellular bases of clinical infectious diseases

Track 14-1Cellular and Molecular Immunology
Track 14-2Molecular Biology and Pathogenesis of Viruses
Track 14-3Host-Pathogen Interactions
Track 14-4Veterinary Pathobiology

Track 15:Epidemiology

Epidemiology is the study of the causes, statistics and health effects of disease conditions in a particular population. Epidemiology shapes policy decisions and proof-based actions through identification of risk factors for disease and targets for preventive health. Epidemiology helps to develop methodology to be used in clinical research studies, and, to a lesser extent, basic research in the biological sciences. Epidemiological studies involve an introduction, entire historical background, surveillance data sources, laboratory diagnosis, the biological characteristics of the organism, mechanisms and routes of transmission, pathogenesis and immunity, host response, and finally prevention, control and treatment. Emerging molecular methods are vast for future efforts. Traditional case control and cohort studies will be needed to define the action of such pathogens in disease causality.

Track 15-1Epidemiology of bacterial infections
Track 15-2Veterinary epidemiology
Track 15-3Plant disease epidemiology
Track 15-4Epidemiology of fungal infections

Track 16:Antimicrobials and Chemotherapy

Antimicrobial compounds either kills or inhibits the growth of other organism. Many microorganisms show this general phenomenon where they produce anti-microbial compounds. Antibiotics are used against bacterial as anti-fungal are against fungi. Broad spectrum antibiotics, various lytic agents which give finest array of defence system. Additional to these, there are various protein moieties which show bactericidal action, like exotoxin and bacteriocins.Antimicrobial therapy implements the clinical use of antimicrobial agents in treating communicable disease. The positive conclusion of this antimicrobial medical care depends on many factors like website of infection, host defense mechanisms and pharmacokinetic and pharmacodynamic activity of the medication agent. A disinfectant activity depends on the microorganism growth and microorganism division. Findings relied upon varied laboratory studies is employed to eliminate microorganism infection from a bunch. because the activity of medication agent depends on its concentration, in vitro characterization of medication activity usually involves the MIC - minimum restrictive concentration and MBC that is that the minimum disinfectant concentration of medication agent. Antimicrobial agents that treat microorganism infections area unit given as medication therapy, equally for plant life, microorganism and protozoan infections area unit they're given as antifungal, antiviral and medication therapy. infective Variation poses a profound challenge in planning a vaccinum.

Track 16-1Dynamics and consequences of antimicrobial resistance
Track 16-2Method and Detection Mechanisms
Track 16-3Antimicrobial Efficacy Test (AET)
Track 16-4Endotoxins and Exotoxins

Track 17:Microbial Biofilms

Biofilms are the assemblage of microorganisms enclosed in an extracellular polymeric substance matrix. The complex process of attachment has diverse characteristics. It is a cascade process with regulated by growth medium, substratum and cell surface. Their role in infectious diseases has led to their increased importance in clinical microbiology. Better understanding and knowledge about biofilms will lead to novel and pivot control of biofilms with improved biofilm management.

Track 17-1Biofilm roles in infections
Track 17-2Resistance to antimicrobial agents

7^th Euro Global Summit on Clinical Microbiology and Mycotoxins February 27-28, 2017 Amsterdam, Netherlands

Recommended Global Microbiology Conferences

USA & Americas

Europe & Middle East

Asia Pacific